Researchers assessed the protective effects of influenza vaccination among older adults with cardiovascular disease.
Vaccines
Pneumococcal 15-Valent Conjugate Vaccine Approved for Pediatric Use
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Challenge Study Shows Efficacy of RSV Vaccine in Healthy Adults
The bivalent prefusion F respiratory syncytial virus vaccine is effective against symptomatic RSV infection and viral shedding.
Exercise May Boost Immune Response to Flu Vaccine
Physical activity and acute exercise offer some benefit for influenza vaccination response, according to a review published online.
Study Shows GSK’s RSV Vaccine Candidate Provides Protection for Older Adults
The vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with an adjuvant.
FDA Approves Additional Option for Measles, Mumps and Rubella Vaccination
Priorix is administered as a 2-dose series (each dose is approximately 0.5mL) via subcutaneous injection.
Improved Meningococcal Vaccine Guidance Needed for Patients With HIV
Researchers estimated uptake of the meningococcal A, C, W, Y vaccine among individuals with newly diagnosed HIV infection at increased risk for meningococcal disease.
The Case for Expanding Pharmacists’ Authority to Administer Vaccines
Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
And Then Came Monkeypox: What to Know About the Recent Outbreak
In this interview, Paritosh Prasad, MD, provides insight into the recent outbreak of monkeypox.
- Loading...
Loading...
Next post in Emerging Diseases
Loading... 
Loading...